Aco Healthcare Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
1. C62 / L154
2. neo Series
3. neo Vet Series
2. neo Series
3. neo Vet Series
The content above was translated by Ai
Founded Year
2019
Unified Business No.
82815411
Status
Active
Number of Employees
0
Total Paid-in
Capital
151,280,996 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Aco Healthcare Co., Ltd., operating under the brand name Aco Smartcare, was founded in 2019. In that same year, we became a subsidiary of Compal Group. Our team specialize in designing and manufacturing in various sectors, including hardware, software, and transducer modules.
Our strength lies in developing advanced technology solutions that fulfill clinical needs, optimize workflow, and meet customization requirements. We consistently deliver high-quality products and are committed to providing excellent post-sales support to our valued customers.
Our strength lies in developing advanced technology solutions that fulfill clinical needs, optimize workflow, and meet customization requirements. We consistently deliver high-quality products and are committed to providing excellent post-sales support to our valued customers.
The content above was translated by Ai
